dockets: FDA-2022-N-2390

Regulatory dockets from Regulations.gov — containers for related documents and comments in a rulemaking proceeding.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id title docket_type last_modified object_id rin dkabstract category subtype keywords program short_title effective_date organization attrs_raw attr_source
FDA-2022-N-2390 FDA Proposal To Refuse To Approve a New Drug Application Supplement for Hetlioz (Tasimelteon); Opportunity for a Hearing Nonrulemaking 2026-06-30T16:37:09Z 0b000064853748a9         ["Proposal To Refuse To Approve a New Drug", "Application Supplement for Hetlioz", "(Tasimelteon); Opportunity for a Hearing", "Notice", "CDER", "2022-536", "Open"] CDER Proposal To Refuse To Approve a New Drug Application Supplement for Hetlioz (Tasimelteon); Opportunity for a Hearing     {"displayProperties": [{"name": "generic", "label": "Docket Item Code", "tooltip": "An agency specific code that identifies the type of document that established the docket (regulatory action)."}, {"name": "program", "label": "Center", "tooltip": "The agency specific program associated with the docket (regulatory action); equivalents: Docket Item Code, Location."}, {"name": "field2", "label": "Docket Status", "tooltip": "Used to Identity that a Docket's Status is Open or Closed"}, {"name": "shortTitle", "label": "Short Title", "tooltip": "A combination of letters and or numbers assigned to an agency's regulatory action for purposes of brevity."}], "keywords": ["Proposal To Refuse To Approve a New Drug", "Application Supplement for Hetlioz", "(Tasimelteon); Opportunity for a Hearing", "Notice", "CDER", "2022-536", "Open"], "modifyDate": "2026-06-30T16:37:09Z", "dkAbstract": null, "agencyId": "FDA", "program": "CDER", "shortTitle": "Proposal To Refuse To Approve a New Drug Application Supplement for Hetlioz (Tasimelteon); Opportunity for a Hearing", "subType2": null, "title": "Proposal To Refuse To Approve a New Drug Application Supplement for Hetlioz (Tasimelteon); Opportunity for a Hearing", "generic": "N", "field1": null, "docketType": "Nonrulemaking", "petitionNbr": null, "rin": null, "organization": null, "legacyId": null, "subType": null, "category": null, "field2": "Open", "effectiveDate": null, "objectId": "0b000064853748a9"} single_get

Links from other tables